Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Synovus (SNV) have what it takes? Let's find out.

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

T. Rowe Price's Q2-2025 saw continued net outflows, with no clear catalyst for a turnaround. Read why TROW stock remains a ...

Let’s start with the stock price. BMO shares recently traded at around $154 as of early August 2025. That’s up over 37% from ...

The most recent payout was $0.3331 per share, putting the annualized dividend at $1.33 and giving it a forward yield of 2.7% as of writing ... Its beta is just 0.28, meaning it barely flinches when ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...

Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Put simply, these types of businesses are compounding ...

Portfolio status: 100% of loans were performing as of Q2 2025; weighted average risk rating held steady at 2.9, with no ...

Learn more about whether Calix, Inc. or CommScope Holding Company, Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether ADMA Biologics, Inc. or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ Investor ...

In this special panel session for Livewire Markets’ 2025 Income Series, three seasoned portfolio managers share their sharply contrasting strategies and what they believe are the biggest risks and ...